Liang Rong, van den Hurk Jan V, Zheng Chunfu, Yu Hong, Pontarollo Reno A, Babiuk Lorne A, van Drunen Littel-van den Hurk Sylvia
Vaccine and Infectious Disease Organization, University of Saskatchewan, Sask., Canada S7N 5E3.
Vaccine. 2005 Nov 1;23(45):5252-62. doi: 10.1016/j.vaccine.2005.06.025. Epub 2005 Jul 13.
The major protective antigen of bovine viral diarrhea virus (BVDV), the E2 protein, is cell-associated and not expressed on the cell surface. In this study we evaluated a DNA vaccine encoding various secreted versions of E2. In vitro analysis demonstrated that deletion of the transmembrane anchor and addition of the signal sequence of bovine herpesvirus-1 (BHV-1) (gDsDeltaE2) resulted in efficient secretion of E2 into the culture medium. In contrast, full-length E2, either without or with gDs (gDsE2), as well as truncated E2 without gDs (DeltaE2), remained entirely cell-associated. Mice immunized with plasmid encoding gDsDeltaE2 developed significantly higher IgG and virus neutralizing antibody titres compared to animals vaccinated with plasmid encoding E2, DeltaE2 or gDsE2. To optimize secretion of E2, the efficiency of gDs was compared with that of the tissue plasminogen activator signal (tPAs) sequence. In addition, the effect of the plasmid backbone was assessed by comparing two vectors. Four plasmids, pMASIA-gDsDeltaE2, pMASIA-tPAsDeltaE2, pSLKIA-gDsDeltaE2 and pSLKIA-tPAsDeltaE2, were constructed and administered intradermally to mice. The mice immunized with pMASIA-tPAsDeltaE2 developed the strongest and most balanced immune responses. Vaccination of cattle confirmed that pMASIA-tPAsDeltaE2 elicited both strong humoral and cellular immune responses and thus could be a candidate DNA vaccine against BVDV.
牛病毒性腹泻病毒(BVDV)的主要保护性抗原E2蛋白与细胞相关,不在细胞表面表达。在本研究中,我们评估了一种编码各种分泌型E2的DNA疫苗。体外分析表明,删除跨膜锚定区并添加牛疱疹病毒-1(BHV-1)的信号序列(gDsDeltaE2)可使E2有效分泌到培养基中。相比之下,全长E2(无论有无gDs,即gDsE2)以及无gDs的截短型E2(DeltaE2)仍完全与细胞相关。与接种编码E2、DeltaE2或gDsE2质粒的动物相比,用编码gDsDeltaE2的质粒免疫的小鼠产生的IgG和病毒中和抗体滴度显著更高。为了优化E2的分泌,将gDs的效率与组织纤溶酶原激活剂信号(tPAs)序列的效率进行了比较。此外,通过比较两种载体评估了质粒骨架的作用。构建了四种质粒pMASIA-gDsDeltaE2、pMASIA-tPAsDeltaE2、pSLKIA-gDsDeltaE2和pSLKIA-tPAsDeltaE2,并将其皮内注射给小鼠。用pMASIA-tPAsDeltaE2免疫的小鼠产生了最强且最平衡的免疫反应。牛的疫苗接种证实,pMASIA-tPAsDeltaE2能引发强烈的体液免疫和细胞免疫反应,因此可能是一种抗BVDV的候选DNA疫苗。